Statistical Analysis of FDA's Inspection Findings
Recommendation

22/23 September 2026
Organisation of a GMP-compliant Site Change
The deficiencies observed by FDA inspectors are written down in the so-called Form 483. Unlike Warning Letters, those aren't available online and have to be requested individually by post. Yet, FDA's evaluation of findings listed according to their frequency is pretty unknown. This is a very easy way to find out frequently observed deficiencies. In the fields "Drugs" for example, the lack of or the non-compliance with written instructions is ranked first. The second position goes to failures in the investigation of deviations.
The observation summary counts more than 5.000 483 Forms - including in addition to drugs also further fields like foods which have been analysed separately.
Another interesting summary is the webpage with FAQs relating to the 483 Form.
The following graph shows an analysis of the 483 identified during fiscal year 2013.

Related GMP News
22.07.2026Deviations in Aseptic Manufacturing: Warning Letter to a Japanese Pharmaceutical Manufacturer
15.07.2026The Relationship between Commissioning, Classification and Qualification in GMP Cleanrooms
01.07.2026Visual Inspection Group Developments [January through April 2026]
10.06.2026New Edition of ISO 14644-15 published
10.06.2026Revision of the DIN 11865 Standard for Stainless-Steel Components


